Pasar al contenido principal

METALOPROTEINASA-9 Y DEPRESION: ESTUDIO EN UN MODELO ANIMAL Y EN MUESTRAS CEREBRALES HUMANAS POSTMORTEN, Y PAPEL EN EL MECANISMO DE ACCION DE ANTIDEPRESIVOS DE ACCION RAPIDA

RTI2018-097534-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE CANTABRIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Structural connectivity and subcellular changes after antidepressant doses of ketamine and Ro 25-6981 in the rat: an MRI and immuno-labeling study

  • Pascual-Antón, Raquel
  • Blasco-Serra, Arantxa
  • Muñoz-Moreno, Emma
  • Pilar-Cuéllar, Fuencisla
  • Garro-Martínez, Emilio
  • Florensa-Zanuy, Eva
  • López-Gil, Xavier
  • Campa, Víctor M.
  • Soria Rodríguez, Guadalupe
  • Adell, Albert
Ketamine has rapid and robust antidepressant effects. However, unwanted psychotomimetic effects limit its widespread use. Hence, several studies examined whether GluN2B-subunit selective NMDA antagonists would exhibit a better therapeutic profile. Although preclinical work has revealed some of the mechanisms of action of ketamine at cellular and molecular levels, the impact on brain circuitry is poorly understood. Several neuroimaging studies have examined the functional changes in the brain induced by acute administration of ketamine and Ro 25-6981 (a GluN2B-subunit selective antagonist), but the changes in the microstructure of gray and white matter have received less attention. Here, the effects of ketamine and Ro 25-6981 on gray and white matter integrity in male Sprague–Dawley rats were determined using diffusion-weighted magnetic resonance imaging (DWI). In addition, DWI-based structural brain networks were estimated and connectivity metrics were computed at the regional level. Immunohistochemical analyses were also performed to determine whether changes in myelin basic protein (MBP) and neurofilament heavy-chain protein (NF200) may underlie connectivity changes. In general, ketamine and Ro 25-6981 showed some opposite structural alterations, but both compounds coincided only in increasing the fractional anisotropy in infralimbic prefrontal cortex and dorsal raphe nucleus. These changes were associated with increments of NF200 in deep layers of the infralimbic cortex (together with increased MBP) and the dorsal raphe nucleus. Our results suggest that the synthesis of NF200 and MBP may contribute to the formation of new dendritic spines and myelination, respectively. We also suggest that the increase of fractional anisotropy of the infralimbic and dorsal raphe nucleus areas could represent a biomarker of a rapid antidepressant response., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This work was supported by grants from the Instituto de Salud Carlos III, Subdirección General de Evaluación y Fomento de la Investigación (PI13/00038, PI16/00217 and PI19/00170 to A.A.) that were co-funded by the European Regional Development Fund (‘A way to build Europe’); Generalitat Valenciana, Conselleria d’ Educació, Investigació, Cultura i Esport (GV/2018/049 to A.B-S.); Ministerio de Ciencia, Innovación y Universidades (RTI2018-097534-B-I00 to F.P.-C.). Funding from the Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III is also acknowledged. The funding agencies had no role in the design and conduct of the study, collection, management, analyses, and interpretation of the data; and preparation, review, or approval of the manuscript and the decision to submit it for publication.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Antidepressant-like effect and molecular mechanism of action of cannabidiol in the lipopolysaccharide model of depression in mice

  • Florensa-Zanuy, Eva
  • Architravo, Annamaria
  • Adell, Albert
  • Garro-Martínez, Emilio
  • Castro, Elena
  • Díaz, Álvaro
  • Pazos, Ángel
  • Pilar-Cuéllar, Fuencisla
Resumen del trabajo presentado en el 33rd ECNP Congress Virtual, celebrado en modalidad virtual del 12 al 15 de septiembre de 2020., Major Depression is an incapacitating disease spread worldwide. As its etiology is still unknown, some hypotheses have been postulated, being the neuro-inflammatory one of the most recent. The current treatment for depression is far from optimal and there is an urgent need to find fast-acting drugs with fewer side effects. In this regard, cannabidiol (CBD), the major non-psychotropic component of , appears as a promising antidepressant drug. We have evaluated CBD’s behavioural and molecular effects in a neuro-inflammatory model of depression induced by lipopolysaccharide (LPS)., This research was supported by the Ministerio de Economía y Competitividad (SAF2015-67457-R MINECO/FEDER), the Ministerio de Ciencia Innovación y Universidades (RTI2018-097534-B-I00), and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM CB/07/09/0029).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cannabidiol antidepressant-like effect in the lipopolysaccharide model in mice: Modulation of inflammatory pathways

  • Florensa-Zanuy, Eva
  • Garro-Martínez, Emilio
  • Adell, Albert
  • Castro, Elena
  • Díaz, Álvaro
  • Pazos, Ángel
  • Mac-Dowell, Karina S.
  • Martín-Hernández, David
  • Pilar-Cuéllar, Fuencisla
Major Depression is a severe psychiatric condition with a still poorly understood etiology. In the last years, evidence supporting the neuroinflammatory hypothesis of depression has increased. In the current clinical scenario, in which the available treatments for depression is far from optimal, there is an urgent need to develop fast-acting drugs with fewer side effects. In this regard, recent pieces of evidence suggest that cannabidiol (CBD), the major non-psychotropic component of Cannabis sativa with anti-inflammatory properties, appears as a drug with antidepressant properties. In this work, CBD 30 mg/kg was administered systemically to mice 30 min before lipopolysaccharide (LPS; 0.83 mg/kg) administration as a neuroinflammatory model, and behavioral tests for depressive-, anhedonic- and anxious-like behavior were performed. NF-ĸB, IκBα and PPARγ levels were analyzed by western blot in nuclear and cytosolic fractions of cortical samples. IL-6 and TNFα levels were determined in plasma and prefrontal cortex using ELISA and qPCR techniques, respectively. The precursor tryptophan (TRP), and its metabolites kynurenine (KYN) and serotonin (5-HT) were measured in hippocampus and cortex by HPLC. The ratios KYN/TRP and KYN/5-HT were used to estimate indoleamine 2,3-dioxygenase (IDO) activity and the balance of both metabolic pathways, respectively. CBD reduced the immobility time in the tail suspension test and increased sucrose preference in the LPS model, without affecting locomotion and central activity in the open-field test. CBD diminished cortical NF-ĸB activation, IL-6 levels in plasma and brain, and the increased KYN/TRP and KYN/5-HT ratios in hippocampus and cortex in the LPS model. Our results demonstrate that CBD produced antidepressant-like effects in the LPS neuroinflammatory model, associated to a reduction in the kynurenine pathway activation, IL-6 levels and NF-ĸB activation. As CBD stands out as a promising antidepressant drug, more research is needed to completely understand its mechanisms of action in depression linked to inflammation., This research was supported by the Ministerio de Economía y Competitividad (SAF2015-67457-R MINECO/FEDER), the Ministerio de Ciencia, Innovacion ´ y Universidades (RTI2018-097534-B-I00), the Instituto de Salud Carlos III (PI19/00170), and Centro de Investigacion ´ Biom´edica en Red de Salud Mental (CIBERSAM). E F-Z was supported by a predoctoral fellowship from the Universidad de Cantabria (Spain).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

5-HT4Receptors Are Not Involved in the Effects of Fluoxetine in the Corticosterone Model of Depression

  • Amigó, Josep
  • Garro-Martínez, Emilio
  • Vidal, Rebeca
  • Compan, V.
  • Pilar-Cuéllar, Fuencisla
  • Pazos, Ángel
  • Díaz, Álvaro
  • Castro, Elena
Clinical and preclinical studies report the implication of 5-hydroxytryptamine 4 receptors (5-HT4Rs) in depression and anxiety. Here, we tested whether the absence of 5-HT4Rs influences the response to the antidepressant fluoxetine in mice subjected to chronic corticosterone administration, an animal model of depression and anxiety. Therefore, the effects of chronic administration of fluoxetine in corticosterone-treated wild-type (WT) and 5-HT4R knockout (KO) mice were evaluated in the open-field and novelty suppressed feeding tests. As 5-HT1A receptor (5-HT1AR) and brain-derived neurotrophic factor (BDNF) are critically involved in depression and anxiety, we further evaluated 5-HT1A receptor functionality by [35S]GTPγS autoradiography and BDNF mRNA expression by in situ hybridization techniques. We found that 5-HT4R KO and WT mice displayed anxiety- and depressive-like behavior following chronic administration of corticosterone, as evidenced in the open-field and novelty suppressed feeding tests. In the open-field, a decreased central activity was observed in naı̈ve and corticosterone-treated mice of both genotypes following chronic fluoxetine administration. In the novelty suppressed feeding test, a predictive paradigm of antidepressant activity, chronic treatment with fluoxetine reverted the latency to eat in both genotypes. The antidepressant also potentiated the corticosterone-induced desensitization of the 5-HT1AR in the dorsal raphe nucleus. Further, chronic fluoxetine increased BDNF mRNA expression in the dentate gyrus of the hippocampus in corticosterone-treated mice of both genotypes. Therefore, our findings indicate that the behavioral effects of fluoxetine in the corticosterone model of depression and anxiety appear not to be dependent on 5-HT4Rs., This research was supported by Ministerio de Economía y Competitividad (SAF2011-25020 and SAF2015-67457-R), Ministerio de Ciencia, Innovación y Universidades (RTI2018-097534-B-I00), and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

mTOR knockdown in the infralimbic cortex evokes a depressive-like state in mouse

  • Garro-Martínez, Emilio
  • Fullana, Neus
  • Florensa-Zanuy, Eva
  • Senserrich, Júlia
  • Paz, Verónica
  • Ruiz-Bronchal, Esther
  • Adell, Albert
  • Castro, Elena
  • Díaz, Álvaro
  • Pazos, Ángel
  • Bortolozzi, Analía
  • Pilar-Cuéllar, Fuencisla
Fast and sustained antidepressant effects of ketamine identified the mammalian target of rapamycin (mTOR) signaling pathway as the main modulator of its antidepressive effects. Thus, mTOR signaling has become integral for the preclinical evaluation of novel compounds to treat depression. However, causality between mTOR and depression has yet to be determined. To address this, we knocked down mTOR expression in mice using an acute intracerebral infusion of small interfering RNAs (siRNA) in the infralimbic (IL) or prelimbic (PrL) cortices of the medial prefrontal cortex (mPFC), and evaluated depressive-and anxious-like behaviors. mTOR knockdown in IL, but not PrL, cortex produced a robust depressive-like phenotype in mice, as assessed in the forced swimming test (FST) and the tail suspension test (TST). This phenotype was associated with significant reductions of mTOR mRNA and protein levels 48 h post-infusion. In parallel, decreased brain-derived neurotrophic factor (BDNF) expression was found bilaterally in both IL and PrL cortices along with a dysregulation of serotonin (5-HT) and glutamate (Glu) release in the dorsal raphe nucleus (DRN). Overall, our results demonstrate causality between mTOR expression in the IL cortex and depressive-like behaviors, but not in anxiety., This research was funded by grants of the Ministerio de Economía y Competitividad (SAF2011-25020 and SAF2015-67457-R MINECO); Ministerio de Ciencia, Innovación y Universidades (RTI2018-097534-B-I00); Ministerio de Ciencia e Innovación (PID2019-105136RB-100); and the European Regional Development Fund (ERDF), UE; Instituto de Salud Carlos III (PI19/00170), and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structural connectivity and subcellular changes after antidepressant doses of ketamine and Ro 25-6981 in the rat: an MRI and immuno-labeling study

  • Pascual-Antón, Raquel
  • Blasco-Serra, Arantxa
  • Muñoz-Moreno, Emma
  • Pilar-Cuéllar, Fuencisla
  • Garro-Martínez, Emilio
  • Florensa-Zanuy, Eva
  • López-Gil, Xavier
  • Campa, Víctor M.
  • Soria, Guadalupe
  • Adell, Albert
© The Author(s) 2021., Ketamine has rapid and robust antidepressant effects. However, unwanted psychotomimetic effects limit its widespread use. Hence, several studies examined whether GluN2B-subunit selective NMDA antagonists would exhibit a better therapeutic profile. Although preclinical work has revealed some of the mechanisms of action of ketamine at cellular and molecular levels, the impact on brain circuitry is poorly understood. Several neuroimaging studies have examined the functional changes in the brain induced by acute administration of ketamine and Ro 25-6981 (a GluN2B-subunit selective antagonist), but the changes in the microstructure of gray and white matter have received less attention. Here, the effects of ketamine and Ro 25-6981 on gray and white matter integrity in male Sprague–Dawley rats were determined using diffusion-weighted magnetic resonance imaging (DWI). In addition, DWI-based structural brain networks were estimated and connectivity metrics were computed at the regional level. Immunohistochemical analyses were also performed to determine whether changes in myelin basic protein (MBP) and neurofilament heavy-chain protein (NF200) may underlie connectivity changes. In general, ketamine and Ro 25-6981 showed some opposite structural alterations, but both compounds coincided only in increasing the fractional anisotropy in infralimbic prefrontal cortex and dorsal raphe nucleus. These changes were associated with increments of NF200 in deep layers of the infralimbic cortex (together with increased MBP) and the dorsal raphe nucleus. Our results suggest that the synthesis of NF200 and MBP may contribute to the formation of new dendritic spines and myelination, respectively. We also suggest that the increase of fractional anisotropy of the infralimbic and dorsal raphe nucleus areas could represent a biomarker of a rapid antidepressant response., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This work was supported by grants from the Instituto de Salud Carlos III, Subdirección General de Evaluación y Fomento de la Investigación (PI13/00038, PI16/00217 and PI19/00170 to A.A.) that were co-funded by the European Regional Development Fund (‘A way to build Europe’); Generalitat Valenciana, Conselleria d’ Educació, Investigació, Cultura i Esport (GV/2018/049 to A.B-S.); Ministerio de Ciencia, Innovación y Universidades (RTI2018-097534-B-I00 to F.P.-C.). Funding from the Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III is also acknowledged.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Autoradiographic Visualization of G Protein-Coupled Receptors in Brain

  • Vidal, Rebeca
  • Pilar-Cuéllar, Fuencisla
  • Díaz, Álvaro
  • Castro, Elena
In this chapter, two in vitro techniques applied to study the anatomical localization of a receptor are revised: firstly, the receptor-binding assay in sections, a technique to assess the location and distribution of a receptor in the tissue (descriptive and anatomical information), and secondly, the [35S]GTPγS-binding assay also in tissue slices, which allows the quantification of the level of G-protein activation by a specific GPCR´s agonist. The latter technique provides additional information about the coupling efficacy of a receptor to G-proteins (functional autoradiography), thus enabling the study of the first step in the intracellular signaling pathway after the receptor activation. Both techniques are basically performed for the in vitro autoradiographic visualization of receptors in tissue slices obtained from animal or human postmortem samples., This work was supported by the Spanish Ministry of Economy and Competitiveness (SAF2015-67457-R MINECO/FEDER) (MINECO/FEDER, UE), the Ministry of Science, Innovation and Universities (RTI2018-097534-B-I00) (MCIU/AEI/ FEDER,UE), and the Instituto de Salud Carlos III.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Radioligand Binding Detection of Receptors in Brain Membranes

  • Pilar-Cuéllar, Fuencisla
  • Garro-Martínez, Emilio
  • Castro, Elena
  • Díaz, Álvaro
Transmitters, hormones, and most of the therapeutic drugs exert their biological functions by generating signals in target cells through interaction with a receptor molecule in the cellular membrane, cytosol, or even at the nucleus of the cell. Because receptors play such a crucial role in cell function, especially within the central nervous system (CNS), we need lab techniques to measure their expression and functionality. There are techniques to determine regulatory changes in receptor number (receptor density), subcellular distribution, anatomical distribution, the physiological function of the receptors as well as the ligand affinity. Here, we describe a classic method in which cells or tissue membranes are exposed to radiolabeled molecules (radioligands) that bind selectively to the receptors in the sample (receptor binding assay). Similarly, the functional consequence of the receptor occupancy or level of G protein activation can be measured by [35S]GTPγS binding assay, also known as functional binding. This assay measures the binding of the nonhydrolyzable analog [35S]GTPγS ([35S]guanosine-5′-O-(3-thio) triphosphate) to Gα subunits. The above radiometric assays are useful to determine the affinity and receptor density of a drug, and to differentiate among agonist, antagonist, and inverse agonist activities, the traditional pharmacological parameters of potency and efficacy, as well as receptor constitutive activity. Moreover, radioligand binding assays provide a powerful tool for screening drug candidates for many receptors in drug discovery research., This work was supported by the Spanish Ministry of Economy and Competitiveness (SAF2015-67457-R MINECO/FEDER) (MINECO/FEDER, UE), the Ministry of Science, Innovation and Universities (RTI2018-097534-B-I00) (MCIU/AEI/FEDER,UE), and the Instituto de Salud Carlos III.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Molecular signaling mechanisms for the antidepressant effects of NLX-101, a selective cortical 5-HT1A receptor biased agonist

  • Cabanu, Sharon
  • Pilar-Cuéllar, Fuencisla
  • Zubakina, Paula
  • Florensa-Zanuy, Eva
  • Senserrich, Júlia
  • Newman-Tancredi, Adrian
  • Adell, Albert
Depression is the most prevalent of the mental illnesses and serotonin (5-hydroxytryptamine, 5-HT) is considered to be the major neurotransmitter involved in its etiology and treatment. In this context, 5-HT1A receptors have attracted interest as targets for therapeutic intervention. Notably the activation of presynaptic 5-HT1A autoreceptors delays antidepressant effects whereas the stimulation of postsynaptic 5-HT1A heteroreceptors is needed for an antidepressant action. NLX-101 (also known as F15599) is a selective biased agonist which exhibits preferred activation of cortical over brain stem 5-HT1A receptors. Here, we used behavioral, neurochemical and molecular methods to examine the antidepressant-like effects in rats of a single dose of NLX-101 (0.16 mg/kg, i.p.). NLX-101 reduced immobility in the forced swim test when measured 30 min but not 24 h after drug administration. NLX-101 increased extracellular concentrations of glutamate and dopamine in the medial prefrontal cortex, but no changes were detected in the efflux of noradrenaline or 5-HT. NLX-101 also produced an increase in the activation of pmTOR, pERK1/2 and pAkt, and the expression of PSD95 and GluA1, which may contribute to its rapid antidepressant action., This research was funded by the Instituto de Salud Carlos III, Subdirección General de Evaluación y Fomento de la Investigación, FIS grant number Pl19/00170 that was co-funded by the European Regional Development Fund (‘A way to build Europe’), the Ministerio de Ciencia, Innovación y Universidades (RTI2018-097534-B-I00), and the Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III (CIBERSAM CB/07/09/0029). E.F.-Z. was recipient of a predoctoral fellowship from the Universidad de Cantabria (Spain). J.S. has a predoctoral contract from the CIBERSAM, Spain. We also acknowledge support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Molecular and neurochemical aspects of the antidepressant effects of NLX-101, a selective cortical 5-HT1A receptor biased agonist

  • Cabanu, Sharon
  • Pilar-Cuéllar, Fuencisla
  • Zubakina, Paula
  • Florensa-Zanuy, Eva
  • Senserrich, Júlia
  • Newman-Tancredi, Adrian
  • Adell, Albert
Trabajo presentado en Cell symposia: the biology of neuropsychiatric disorders, celebrada en Sitges (Barcelona) del 15 al 17 de mayo de 2022., Serotonin is considered to be the major neurotransmitter involved in depression and its treatment. Thus, 5-HT receptors have attracted interest as targets for therapeutic intervention. Notably, the activation of presynaptic 5-HT1A autoreceptors slows down the antidepressant effects of serotonin reuptake inhibitors whereas the stimulation of postsynaptic 5-HT1A heteroreceptors is needed for an antidepressant action. NLX-101 exhibits preferential activation of cortical and brain stem 5-HT1A receptors. Here we used behavioral, neurochemical and molecular methods to examine its antidepressant effects. NLX-101 (0.16 mg/kg) reduced immobility in the forced swim test when measured 30 min (albeit not 24 h and 7 days) after drug administration. NLX-101 increased the dialysate dopamine and glutamate in the medial prefrontal cortex, but no changes were observed in the prefrontal output of noradrenaline and serotonin. NLX-101 also produced a rapid increase in the synthesis of pmTOR, pERK1/2 and pGluA1, which may contribute to its rapid antidepressant action., Instituto de Salud Carlos III, FIS grant number Pl19/00170 that was co-funded by the European Regional Development Fund (‘A way to build Europe’), the Ministerio de Ciencia, Innovación y Universidades (RTI2018-097534-BI00), and the Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III (CIBERSAM CB/07/09/0029).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Brain matrix metalloproteinase-9 activity is altered in the corticosterone mouse model of depression

  • Breviario, Silvia
  • Senserrich, Júlia
  • Florensa-Zanuy, Eva
  • Garro-Martínez, Emilio
  • Díaz, Álvaro
  • Castro, Elena
  • Pazos, Ángel
  • Pilar-Cuéllar, Fuencisla
Major depressive disorder is a highly prevalent psychiatric condition. Metalloproteinase 9 (MMP-9), a gelatinase involved in synaptic plasticity, learning and memory processes, is elevated in both chronic stress animal models and human peripheral blood samples of depressed patients. In this study we have evaluated the MMP-9 activity and protein expression in brain areas relevant to depression using the chronic corticosterone mouse model of depression. These mice show a depressive- and anxious-like behaviour. The MMP-9 activity and protein levels are significantly elevated in both the hippocampus and the cortex, and nectin-3 levels are lower in these brain areas in this model. In particular, these mice display an increased gelatinase activity in the CA1 and CA3 subfields of the hippocampus and in the internal layer of the prefrontal cortex. Moreover, the immobility time in the tail suspension test presents a positive correlation with the cortical MMP-9 activity, and a negative correlation with nectin-3 levels. In conclusion, the chronic corticosterone model of depression leads to an increase in the protein expression and activity of MMP-9 and a reduction of its substrate nectin-3 in relevant areas implicated in this disease. The MMP-9 activity correlates with behavioural despair in this model of depression. All these findings support the role of MMP-9 in the pathophysiology of depression, and as a putative target to develop novel antidepressant drugs., This research was supported by the Ministerio de Ciencia, Innovación y Universidades (RTI2018-097534-B-I00) and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Sex differences in the modulation of anxiety- and depression-like behaviors by matrix metalloproteinase-9 expression levels in mice

  • Senserrich, Júlia
  • Castro, Elena
  • Florensa-Zanuy, Eva
  • Díaz, Álvaro
  • Pazos, Ángel
  • Adell, Albert
  • Tzinia, Athina
  • Pilar-Cuéllar, Fuencisla
[Background] Major depressive disorder is one of the main causes of disability worldwide, but its etiopathology remains largely unknown, although several hypotheses have been proposed. Recent studies suggest a potential role for matrix metalloproteinase 9 (MMP-9) in depression, as it is overexpressed in the plasma of depressed patients and normalizes following chronic antidepressant treatment. This study aimed to characterize anxiety and depression-like behaviors in transgenic MMP-9 mice, as well as the expression of different neuroplasticity markers associated with depression, in both sexes., [Methods] In this study, we characterized the behavioral phenotypes of both MMP-9 knockout and MMP-9-overexpressing male and female mice. Here, we used a battery of tests to assess anxiety (open field, light‒dark box, elevated plus maze, and novelty‒suppressed feeding tests), depressive-like (tail suspension and social interaction tests), and cognitive (T-maze) behaviors., [Results] MMP-9 knockout female mice displayed increased innate anxiety (open field test), decreased behavioral despair (tail suspension test). Compared with control mice, female MMP-9 knockout mice presented increased levels of different neuroplasticity markers in the hippocampus. With respect to MMP-9-overexpressing mice, females presented decreased innate anxiety (elevated plus maze). Male MMP-9-overexpressing mice presented greater conflict-based anxiety (novelty-suppressed feeding test) than control mice did., [Conclusions] MMP-9 activity modifies anxiety- and depression-like behaviors, as well as neuroplasticity markers, in female but not in male mice. These findings reinforce the sex differences in the etiopathology of depression., This research was funded by the Ministerio de Ciencia, Innovación y Universidades (RTI2018-097534-B-I00), Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), the Instituto de Salud Carlos III (FIS Grant PI19-00170), which were co-funded by the European Regional Development Fund (‘A way to build Europe’), and the Spanish Network for Stress Research RED2022-134191-T financed by MCIN/AEI/10.13039/501100011033., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Structural connectivity and subcellular changes after antidepressant doses of ketamine and Ro 25-6981 in the rat: an MRI and immuno-labeling study

  • Pascual-Antón, Raquel
  • Blasco-Serra, Arantxa
  • Muñoz-Moreno, Emma
  • Pilar-Cuéllar, Fuencisla
  • Garro-Martínez, Emilio
  • Florensa-Zanuy, Eva
  • López-Gil, Xavier
  • Campa, Víctor M.
  • Soria Rodríguez, Guadalupe
  • Adell, Albert
Ketamine has rapid and robust antidepressant effects. However, unwanted psychotomimetic effects limit its widespread use. Hence, several studies examined whether GluN2B-subunit selective NMDA antagonists would exhibit a better therapeutic profile. Although preclinical work has revealed some of the mechanisms of action of ketamine at cellular and molecular levels, the impact on brain circuitry is poorly understood. Several neuroimaging studies have examined the functional changes in the brain induced by acute administration of ketamine and Ro 25-6981 (a GluN2B-subunit selective antagonist), but the changes in the microstructure of gray and white matter have received less attention. Here, the effects of ketamine and Ro 25-6981 on gray and white matter integrity in male Sprague–Dawley rats were determined using diffusion-weighted magnetic resonance imaging (DWI). In addition, DWI-based structural brain networks were estimated and connectivity metrics were computed at the regional level. Immunohistochemical analyses were also performed to determine whether changes in myelin basic protein (MBP) and neurofilament heavy-chain protein (NF200) may underlie connectivity changes. In general, ketamine and Ro 25-6981 showed some opposite structural alterations, but both compounds coincided only in increasing the fractional anisotropy in infralimbic prefrontal cortex and dorsal raphe nucleus. These changes were associated with increments of NF200 in deep layers of the infralimbic cortex (together with increased MBP) and the dorsal raphe nucleus. Our results suggest that the synthesis of NF200 and MBP may contribute to the formation of new dendritic spines and myelination, respectively. We also suggest that the increase of fractional anisotropy of the infralimbic and dorsal raphe nucleus areas could represent a biomarker of a rapid antidepressant response., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This work was supported by grants from the Instituto de Salud Carlos III, Subdirección General de Evaluación y Fomento de la Investigación (PI13/00038, PI16/00217 and PI19/00170 to A.A.) that were co-funded by the European Regional Development Fund (‘A way to build Europe’); Generalitat Valenciana, Conselleria d’ Educació, Investigació, Cultura i Esport (GV/2018/049 to A.B-S.); Ministerio de Ciencia, Innovación y Universidades (RTI2018-097534-B-I00 to F.P.-C.). Funding from the Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III is also acknowledged. The funding agencies had no role in the design and conduct of the study, collection, management, analyses, and interpretation of the data; and preparation, review, or approval of the manuscript and the decision to submit it for publication.